79 related articles for article (PubMed ID: 29397821)
21. [HER2 Expression in Childhood ETV6/RUNX1
Sun CC; Chang LX; Zhu S; Liu C; Lan Y; Chen XY; Liu F; Chen YM; Zou Y; Zhu XF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):642-646. PubMed ID: 29950197
[TBL] [Abstract][Full Text] [Related]
22. Impact of chromosomal translocations on prognosis in childhood acute lymphoblastic leukemia.
Rubin CM; Le Beau MM; Mick R; Bitter MA; Nachman J; Rudinsky R; Appel HJ; Morgan E; Suarez CR; Schumacher HR
J Clin Oncol; 1991 Dec; 9(12):2183-92. PubMed ID: 1960559
[TBL] [Abstract][Full Text] [Related]
23. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
[TBL] [Abstract][Full Text] [Related]
24. Sex differences in prognosis for children with acute lymphoblastic leukemia.
Pui CH; Boyett JM; Relling MV; Harrison PL; Rivera GK; Behm FG; Sandlund JT; Ribeiro RC; Rubnitz JE; Gajjar A; Evans WE
J Clin Oncol; 1999 Mar; 17(3):818-24. PubMed ID: 10071272
[TBL] [Abstract][Full Text] [Related]
25. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
Lu XT
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
[TBL] [Abstract][Full Text] [Related]
26. [Immunophenotyping characteristics of adult patients with acute lymphoblastic leukemia in different ages].
Ma J; Liu YF; Chen SM; Zhang QT; Sun L; Liu LX; Wan DM; Chen SQ; Xie XS; Meng XL; Jiang ZX; Cheng YD; Wang F; Sun H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):942-5. PubMed ID: 20723305
[TBL] [Abstract][Full Text] [Related]
27. [Analysis of Prognostic Factors for 96 Patients with Acute Lymphoblastic Leukemia].
DU ZY; Yang RY; Li C; Duan LJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1005-1010. PubMed ID: 30111398
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in childhood acute lymphoblastic leukemia.
Jia M; Zhao HZ; Shen HP; Cheng YP; Luo ZB; Li SS; Zhang JY; Tang YM
Int J Lab Hematol; 2015 Oct; 37(5):631-40. PubMed ID: 25955539
[TBL] [Abstract][Full Text] [Related]
29. Clinical importance of myeloid antigen expression in Moroccan patients with adult B-lineage acute lymphoblastic leukemia.
Lahjouji A; Bachir F; Bennani S; Benchekroun S; E SA
Neoplasma; 2013; 60(5):553-60. PubMed ID: 23790175
[TBL] [Abstract][Full Text] [Related]
30. CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia.
Thomas X; Archimbaud E; Charrin C; Magaud JP; Fiere D
Leukemia; 1995 Feb; 9(2):249-53. PubMed ID: 7532767
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
32. [A clinicopathological study of 96 cases of lymphoblastic lymphoma].
Pan Y; Liu WP; Li JF; Zhang WY; Li FY; Lu XX; Li D; Li GD
Zhonghua Xue Ye Xue Za Zhi; 2005 Apr; 26(4):218-22. PubMed ID: 15949264
[TBL] [Abstract][Full Text] [Related]
33. Acute lymphoblastic leukemia in the elderly: The Edouard Herriot Hospital experience.
Thomas X; Olteanu N; Charrin C; Lhéritier V; Magaud JP; Fiere D
Am J Hematol; 2001 Jun; 67(2):73-83. PubMed ID: 11343378
[TBL] [Abstract][Full Text] [Related]
34. Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia.
Mortuza FY; Papaioannou M; Moreira IM; Coyle LA; Gameiro P; Gandini D; Prentice HG; Goldstone A; Hoffbrand AV; Foroni L
J Clin Oncol; 2002 Feb; 20(4):1094-104. PubMed ID: 11844835
[TBL] [Abstract][Full Text] [Related]
35. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
Smith M; Arthur D; Camitta B; Carroll AJ; Crist W; Gaynon P; Gelber R; Heerema N; Korn EL; Link M; Murphy S; Pui CH; Pullen J; Reamon G; Sallan SE; Sather H; Shuster J; Simon R; Trigg M; Tubergen D; Uckun F; Ungerleider R
J Clin Oncol; 1996 Jan; 14(1):18-24. PubMed ID: 8558195
[TBL] [Abstract][Full Text] [Related]
36. Low mRNA expression of the apoptosis-related genes CASP3, CASP8, and FAS is associated with low induction treatment response in childhood acute lymphoblastic leukemia (ALL).
Mata JF; Silveira VS; Mateo EC; Cortez MA; Queiroz RG; Yunes JA; Lee ML; Toledo SR; Petrilli AS; Brandalise SR; Tone LG; Scrideli CA
Pediatr Blood Cancer; 2010 Jul; 55(1):100-7. PubMed ID: 20232432
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study.
Shuster JJ; Wacker P; Pullen J; Humbert J; Land VJ; Mahoney DH; Lauer S; Look AT; Borowitz MJ; Carroll AJ; Camitta B
J Clin Oncol; 1998 Aug; 16(8):2854-63. PubMed ID: 9704739
[TBL] [Abstract][Full Text] [Related]
38. [Clinical and laboratorial analysis for 15 adult cases of mixed phenotypic acute leukemia with Ph chromosome and/or positive BCR-ABL].
Yan LZ; Chen SN; Ping NN; Wang QR; Liu H; Ding ZX; Zhu MQ; Liang JY; Liu DD; Cen JN; Pan JL; Qiu HY; Sun AN; Wu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1116-20. PubMed ID: 24156417
[TBL] [Abstract][Full Text] [Related]
39. [Prognosis and related factors of acute lymphoblastic leukemia].
Zhang W; Fu R; Liu WH; Cheng YQ; Song WX; DU LJ; Ruan EB; Zhang LT; Wang XM; Liang Y; Wang GJ; Qu W; Song J; Zhang RL; Guan J; Li LJ; Zou P; Shao ZH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):1102-6. PubMed ID: 17956700
[TBL] [Abstract][Full Text] [Related]
40. High Ki-67 expression in diffuse large B-cell lymphoma patients with non-germinal center subtype indicates limited survival benefit from R-CHOP therapy.
Li ZM; Huang JJ; Xia Y; Zhu YJ; Zhao W; Wei WX; Jiang WQ; Lin TY; Huang HQ; Guan ZZ
Eur J Haematol; 2012 Jun; 88(6):510-7. PubMed ID: 22413767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
